Helix BioPharma Corp. announce that Mr. Artur Gabor resigned as a director of the Board of the Company. The Company also announce the appointment of Ms. Malgorzata Irena Laube on the Board, with immediate effect.

Ms. Laube has over 19 years of experience in nuclear medicine. In her last role with Alberta Health Services, she was the Department Supervisor, Nuclear Medicine at Royal Alexandra Hospital. Ms. Laube obtained a MSc degree in Environmental Engineering from the Warsaw University of Technology.

Ms. Laube is based in Edmonton, Alberta, Canada.